Licensing & Ventures Group

Slate Bio, Inc.

Year Founded: 2020

Slate Bio Inc. is a privately held pre-clinical stage biotechnology company, spun out of the University of Virginia, creating therapies that restore the body's natural immunological response in various diseases. Slate’s lead compound is a bifunctional IL233 cytokine which augments Tregs and expands tissue-resident Tregs.